Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Nov 23;11(11):CD010274.
doi: 10.1002/14651858.CD010274.pub2.

Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders

Dorie Apollonio  1 , Rose Philipps, Lisa Bero
Affiliations
Meta-Analysis

Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders

Dorie Apollonio et al. Cochrane Database Syst Rev. .

Abstract

Background: Smoking rates in people with alcohol and other drug dependencies are two to four times those of the general population. Concurrent treatment of tobacco dependence has been limited due to concern that these interventions are not successful in this population or that recovery from other addictions could be compromised if tobacco cessation was combined with other drug dependency treatment.

Objectives: To evaluate whether interventions for tobacco cessation are associated with tobacco abstinence for people in concurrent treatment for or in recovery from alcohol and other drug dependence.

Search methods: We searched the Cochrane Tobacco Addiction Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and clinicaltrials.gov databases, with the most recent search completed in August 2016. A grey literature search of conference abstracts from the Society on Nicotine Research and Treatment and the ProQuest database of digital dissertations yielded one additional study, which was excluded.

Selection criteria: We included randomised controlled trials assessing tobacco cessation interventions among people in concurrent treatment for alcohol or other drug dependence or in outpatient recovery programmes.

Data collection and analysis: Two review authors independently assessed study risk of bias and extracted data. We resolved disagreements by consensus. The primary outcome was abstinence from tobacco use at the longest period of follow-up, and the secondary outcome was abstinence from alcohol or other drugs, or both. We reported the strictest definition of abstinence. We summarised effects as risk ratios and 95% confidence intervals (CI). Two clustered studies did not provide intraclass correlation coefficients, and were excluded from the sensitivity analysis. We used the I2 statistic to assess heterogeneity.

Main results: Thirty-five randomised controlled trials, one ongoing, involving 5796 participants met the criteria for inclusion in this review. Included studies assessed the efficacy of tobacco cessation interventions, including counselling, and pharmacotherapy consisting of nicotine replacement therapy (NRT) or non-NRT, or the two combined, in both inpatient and outpatient settings for participants in treatment and in recovery. Most studies did not report information to assess the risk of allocation, selection, and attrition bias, and were classified as unclear.Analyses considered the nature of the intervention, whether participants were in treatment or recovery and the type of dependency. Of the 34 studies included in the meta-analysis, 11 assessed counselling, 11 assessed pharmacotherapy, and 12 assessed counselling in combination with pharmacotherapy, compared to usual care or no intervention. Tobacco cessation interventions were significantly associated with tobacco abstinence for two types of interventions. Pharmacotherapy appeared to increase tobacco abstinence (RR 1.60, 95% CI 1.22 to 2.12, 11 studies, 1808 participants, low quality evidence), as did combined counselling and pharmacotherapy (RR 1.74, 95% CI 1.39 to 2.18, 12 studies, 2229 participants, low quality evidence) at the period of longest follow-up, which ranged from six weeks to 18 months. There was moderate evidence of heterogeneity (I2 = 56% with pharmacotherapy and 43% with counselling plus pharmacotherapy). Counselling interventions did not significantly increase tobacco abstinence (RR 1.33, 95% CI 0.90 to 1.95).Interventions were significantly associated with tobacco abstinence for both people in treatment (RR 1.99, 95% CI 1.59 to 2.50) and people in recovery (RR 1.33, 95% CI 1.06 to 1.67), and for people with alcohol dependence (RR 1.47, 95% CI 1.20 to 1.81) and people with other drug dependencies (RR 1.85, 95% CI 1.43 to 2.40).Offering tobacco cessation therapy to people in treatment or recovery for other drug dependence was not associated with a difference in abstinence rates from alcohol and other drugs (RR 0.97, 95% CI 0.91 to 1.03, 11 studies, 2231 participants, moderate evidence of heterogeneity (I2 = 66%)).Data on adverse effect of the interventions were limited.

Authors' conclusions: The studies included in this review suggest that providing tobacco cessation interventions targeted to smokers in treatment and recovery for alcohol and other drug dependencies increases tobacco abstinence. There was no evidence that providing interventions for tobacco cessation affected abstinence from alcohol and other drugs. The association between tobacco cessation interventions and tobacco abstinence was consistent for both pharmacotherapy and combined counselling and pharmacotherapy, for participants both in treatment and in recovery, and for people with alcohol dependency or other drug dependency. The evidence for the interventions was low quality due primarily to incomplete reporting of the risks of bias and clinical heterogeneity in the nature of treatment. Certain results were sensitive to the length of follow-up or the type of pharmacotherapy, suggesting that further research is warranted regarding whether tobacco cessation interventions are associated with tobacco abstinence for people in recovery, and the outcomes associated with NRT versus non-NRT or combined pharmacotherapy. Overall, the results suggest that tobacco cessation interventions incorporating pharmacotherapy should be incorporated into clinical practice to reduce tobacco addiction among people in treatment for or recovery from alcohol and other drug dependence.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest to report.

Figures

1
1
Study flow diagram.
1.1
1.1. Analysis
Comparison 1 Abstinence, by intervention category, Outcome 1 Counselling.
1.2
1.2. Analysis
Comparison 1 Abstinence, by intervention category, Outcome 2 Pharmacotherapy.
1.3
1.3. Analysis
Comparison 1 Abstinence, by intervention category, Outcome 3 Combined counselling and pharmacotherapy.
2.1
2.1. Analysis
Comparison 2 Abstinence by treatment or recovery subgroup, Outcome 1 Abstinence.
3.1
3.1. Analysis
Comparison 3 Abstinence by type of dependency, Outcome 1 Abstinence.
4.1
4.1. Analysis
Comparison 4 Alcohol or other drug abstinence, Outcome 1 Abstinence at longest follow‐up.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Baltieri 2009 {published data only}
    1. Baltieri DA, Daro FR, Ribeiro PL, Andrade AG. Effects of topiramate or naltrexone on tobacco use among male alcohol‐dependent outpatients. Drug & Alcohol Dependence 2009;105(1‐2):33‐41. - PubMed
    1. Baltieri DA, Daro FR, Ribeiro PL, Andrade AG. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 2008;103(12):2035‐44. [PUBMED: 18855810] - PubMed
Bobo 1996 {published data only}
    1. Bobo JK, Lando HA, Walker RD, McIlvain HE. Predictors of tobacco quit attempts among recovering alcoholics. Journal of Substance Abuse 1996;8(4):431‐43. [PUBMED: 9058355] - PubMed
Bobo 1998 {published data only}
    1. Bobo JK, McIlvain HE, Lando HA, Walker RD, Leed‐Kelly A. Effect of smoking cessation counseling on recovery from alcoholism: findings from a randomized community intervention trial. Addiction 1998;93(6):877‐87. [PUBMED: 9744123] - PubMed
Breland 2014 {published data only}
    1. Breland AB, Almond L, Kienzle J, Ondersma SJ, Hart A, Weaver M, et al. Targeting tobacco in a community‐based addiction recovery cohort: results from a computerized, brief, randomized intervention trial. Contemporary Clinical Trials 2014;38(1):113‐20. [CENTRAL: 994445; CRS: 9400129000002277; EMBASE: 2014317617] - PubMed
Burling 1991 {published data only}
    1. Burling TA, Marshall GD, Seidner AL. Smoking cessation for substance abuse inpatients. Journal of Substance Abuse 1991;3(3):269‐76. [PUBMED: 1668228] - PubMed
Burling 2001 {published data only}
    1. Burling TA, Burling AS, Latini D. A controlled smoking cessation trial for substance‐dependent inpatients. Journal of Consulting and Clinical Psychology 2001;69(2):295‐304. [PUBMED: 11393606] - PubMed
Campbell 1995 {published data only}
    1. Campbell BK, Wander N, Stark MJ, Holbert T. Treating cigarette‐smoking in drug‐abusing clients. Journal of Substance Abuse Treatment 1995;12(2):89‐94. [CENTRAL: 116489; CRS: 9400123000000699; EMBASE: 1995142232; PUBMED: 7623395] - PubMed
Carmody 2012 {published data only}
    1. Carmody TP, Delucchi K, Duncan CL, Banys P, Simon JA, Solkowitz SN, et al. Intensive intervention for alcohol‐dependent smokers in early recovery: a randomized trial. Drug & Alcohol Dependence 2012;122(3):186‐94. [PUBMED: 22014532] - PMC - PubMed
    1. Carmody TP, Delucchi K, Simon JA, Duncan CL, Solkowitz SN, Huggins J, et al. Expectancies regarding the interaction between smoking and substance use in alcohol‐dependent smokers in early recovery. Psychology of Addictive Behaviors 2012;26(2):358‐63. [PUBMED: 21707127] - PMC - PubMed
Cooney 2007 {published data only}
    1. Cooney NL, Litt MD, Cooney JL, Pilkey DT, Steinberg HR, Oncken CA. Concurrent brief versus intensive smoking intervention during alcohol dependence treatment. Psychology of Addictive Behaviors 2007;21(4):570‐5. [PUBMED: 18072840] - PMC - PubMed
    1. Holt LJ, Litt MD, Cooney NL. Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment. Psychology of Addictive Behaviors 2012;26(3):561‐72. [CENTRAL: 854421; EMBASE: 2013467232; CRS: 9400123000017550; PUBMED: 22023022] - PMC - PubMed
    1. Kelly MM, Grant C, Cooper S, Cooney JL. Anxiety and smoking cessation outcomes in alcohol‐dependent smokers. Nicotine & Tobacco Research 2013;15(2):364‐75. [CENTRAL: 865747; CRS: 9400107000000696; PUBMED: 22955245] - PubMed
Cooney 2009 {published data only}
    1. Cooney NL, Cooney JL, Perry BL, Carbone M, Cohen EH, Steinberg HR, et al. Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum. Addiction (Abingdon, England) 2009;104(9):1588‐96. [PUBMED: 19549054] - PMC - PubMed
Cooney 2015 {published data only}
    1. Cooney NL, Litt MD, Sevarino KA, Levy L, Kranitz LS, Sackler H, et al. Concurrent alcohol and tobacco treatment: Effect on daily process measures of alcohol relapse risk. Journal of Consulting and Clinical Psychology 2015;83(2):346‐58. [CRS: 9400131000001440; EMBASE: 2015693711] - PMC - PubMed
Gariti 2002 {published data only}
    1. Gariti P, Alterman A, Mulvaney F, Mechanic K, Dhopesh V, Yu E, et al. Nicotine intervention during detoxification and treatment for other substance use. American Journal of Drug and Alcohol Abuse 2002;28(4):671‐9. [PUBMED: 12492263] - PubMed
Grant 2003 {published data only}
    1. Grant KM, Northrup JH, Agrawal S, Olsen DM, McIvor C, Romberger DJ. Smoking cessation in outpatient alcohol treatment. Addictive Disorders & Their Treatment 2003;2(2):41‐6.
Grant 2007 {published data only}
    1. Grant KM, Kelley SS, Smith LM, Agrawal S, Meyer JR, Romberger DJ. Bupropion and nicotine patch as smoking cessation aids in alcoholics. Alcohol (Fayetteville, N.Y.) 2007;41(5):381‐91. [PUBMED: 17889314] - PMC - PubMed
Hays 2009 {published data only}
    1. Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA. A randomized, controlled trial of bupropion sustained‐release for preventing tobacco relapse in recovering alcoholics. Nicotine & Tobacco Research 2009;11(7):859‐67. [PUBMED: 19483180] - PMC - PubMed
Heydari 2013 {published data only}
    1. Heydari G, Talischi F, Batmanghelidj E, Pajooh MR, Boroomand A, Zamani M, et al. Dual addictions, parallel treatments: nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 2014;19 Suppl 3:S25‐31. - PubMed
Hughes 2003 {published data only}
    1. Hughes JR, Novy P, Hatsukami DK, Jensen J, Callas PW. Efficacy of nicotine patch in smokers with a history of alcoholism. Alcoholism, Clinical and Experimental Research 2003;27(6):946‐54. [PUBMED: 12824815] - PubMed
Joseph 2004 {published data only}
    1. Fu SS, Kodl M, Willenbring M, Nelson DB, Nugent S, Gravely AA, et al. Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment. Drug and Alcohol Dependence 2008;92(1):61‐8. [CENTRAL: 702729; CRS: 9400123000005271; PUBMED: 17689205] - PMC - PubMed
    1. Joseph AM, Nelson DB, Nugent SM, Willenbring ML. Timing of alcohol and smoking cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial. Journal of Addictive Diseases 2003;22(4):87‐107. - PubMed
    1. Joseph AM, Willenbring ML, Nelson D, Nugent SM. Timing of alcohol and smoking cessation study. Alcoholism, Clinical and Experimental Research 2002;26(12):1945‐6. [PUBMED: 12500130] - PubMed
    1. Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol 2004;65(6):681‐91. [PUBMED: 15700504] - PubMed
Kalman 2001 {published data only}
    1. Kalman D, Hayes K, Colby SM, Eaton CA, Rohsenow DJ, Monti PM. Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery. A pilot study. Journal of Substance Abuse Treatment 2001;20(3):233‐8. [PUBMED: 11516593] - PubMed
Kalman 2011 {published data only}
    1. Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, et al. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double‐blind, placebo‐controlled study. Drug and Alcohol Dependence 2011;118(2‐3):111‐8. [PUBMED: 21507585] - PMC - PubMed
Karam‐Hage 2011 {published data only}
    1. Karam‐Hage M, Strobbe S, Robinson JD, Brower KJ. Bupropion‐SR for smoking cessation in early recovery from alcohol dependence: a placebo‐controlled, double‐blind pilot study. American Journal of Drug and Alcohol Abuse 2011;37(6):487‐90. [PUBMED: 21797811] - PMC - PubMed
Martin 1997 {published data only}
    1. Martin JE, Calfas KJ, Patten CA, Polarek M, Hofstetter CR, Noto J, et al. Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one‐year results of Project SCRAP‐Tobacco. Journal of Consulting and Clinical Psychology 1997;65(1):190‐4. [PUBMED: 9103749] - PubMed
    1. Patten CA, Martin JE, Calfas KJ, Brown SA, Schroeder DR. Effect of three smoking cessation treatments on nicotine withdrawal in 141 abstinent alcoholic smokers. Addictive Behaviors 2000;25(2):301‐6. - PubMed
    1. Patten CA, Martin JE, Calfas KJ, Lento J, Wolter TD. Behavioral treatment for smokers with a history of alcoholism: predictors of successful outcome. Journal of Consulting and Clinical Psychology 2001;69(5):796‐801. [PUBMED: 11680556] - PubMed
Mooney 2008 {published data only}
    1. Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M. Preliminary study of buprenorphine and bupropion for opioid‐dependent smokers. American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2008;17(4):287‐92. [PUBMED: 18612883] - PMC - PubMed
Mueller 2012 {published data only}
    1. Mueller SE, Petitjean SA, Wiesbeck GA. Cognitive behavioral smoking cessation during alcohol detoxification treatment: a randomized, controlled trial. Drug and Alcohol Dependence 2012;126(3):279‐85. [CENTRAL: 845210; CRS: 9400123000014751; PUBMED: 22726914] - PubMed
Nahvi 2014 {published data only}
    1. Nahvi S, Ning Y, Segal KS, Richter KP, Arnsten JH. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo‐controlled trial. Addiction (Abingdon, England) 2014;109(9):1554‐63. [CENTRAL: 997902; CRS: 9400129000002315; PUBMED: 24862167] - PMC - PubMed
Nieva 2011 {published data only}
    1. Nieva G, Ortega LL, Mondon S, Ballbe M, Gual A. Simultaneous versus delayed treatment of tobacco dependence in alcohol‐dependent outpatients. European Addiction Research 2011;17(1):1‐9. [PUBMED: 20881400] - PubMed
Patten 1998 {published data only}
    1. Patten CA, Martin JE, Myers MG, Calfas KJ, Williams CD. Effectiveness of cognitive‐behavioral therapy for smokers with histories of alcohol dependence and depression. Journal of Studies on Alcohol 1998;59(3):327‐35. [PUBMED: 9598714] - PubMed
Reid 2008 {published data only}
    1. Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, et al. Smoking cessation treatment in community‐based substance abuse rehabilitation programs. Journal of Substance Abuse Treatment 2008;35(1):68‐77. [PUBMED: 17951021] - PubMed
Rohsenow 2014 {published data only}
    1. Rohsenow DJ, Martin RA, Monti PM, Colby SM, Day AM, Abrams DB, et al. Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment. Journal of Substance Abuse Treatment 2014;46(3):346‐55. [CENTRAL: 959232; CRS: 9400130000000480; EMBASE: 2014038589; PUBMED: 24210533] - PMC - PubMed
    1. Rohsenow DJ, Monti PM, Colby SM, Martin RA. Brief interventions for smoking cessation in alcoholic smokers. Alcoholism, Clinical and Experimental Research 2002;26(12):1950‐1. [PUBMED: 12500132] - PubMed
Rohsenow 2015a {published data only}
    1. Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Sirota AD, Swift RM, et al. Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment. Journal of Substance Abuse Treatment 2015;55:29‐38. [CRS: 9400131000001664; EMBASE: 2015852230; PUBMED: 25805668] - PMC - PubMed
Shoptaw 2002 {published data only}
    1. Shoptaw S, Rotheram‐Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, et al. Smoking cessation in methadone maintenance. Addiction (Abingdon, England) 2002;97(10):1317‐28; discussion 1325. [PUBMED: 12359036] - PubMed
Stein 2006 {published data only}
    1. Stein MD, Weinstock MC, Herman DS, Anderson BJ, Anthony JL, Niaura R. A smoking cessation intervention for the methadone‐maintained. Addiction (Abingdon, England) 2006;101(4):599‐607. [PUBMED: 16548939] - PubMed
Stein 2013 {published data only}
    1. Stein MD, Caviness CM, Kurth ME, Audet D, Olson J, Anderson BJ. Varenicline for smoking cessation among methadone‐maintained smokers: a randomized clinical trial. Drug and Alcohol Dependence 2013;133(2):486‐93. [CENTRAL: 870955; CRS: 9400107000001457; EMBASE: 2013694276; PUBMED: 23953658] - PMC - PubMed
Winhusen 2014 {published data only}
    1. Winhusen TM, Adinoff B, Lewis DF, Brigham GS, Gardin JG 2nd, Sonne SC, et al. A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug and Alcohol Dependence 2013;133(3):845‐51. - PMC - PubMed
    1. Winhusen TM, Brigham GS, Kropp F, Lindblad R, Gardin JG 2nd, Penn P, et al. A randomized trial of concurrent smoking‐cessation and substance use disorder treatment in stimulant‐dependent smokers. Journal of Clinical Psychiatry 2014;75(4):336‐43. [CENTRAL: 883292; CRS: 9400129000001165; EMBASE: 2014305114; PUBMED: 24345356] - PMC - PubMed
    1. Winhusen TM, Kropp F, Theobald J, Lewis DF. Achieving smoking abstinence is associated with decreased cocaine use in cocaine‐dependent patients receiving smoking‐cessation treatment. Drug and Alcohol Dependence 2014;134(1):391‐5. [CENTRAL: 979803; CRS: 9400130000000510; EMBASE: 2013788642; PUBMED: 24128381] - PMC - PubMed

References to studies excluded from this review

Alessi 2006 {published data only}
    1. NCT00408265. Smoking cessation in substance abuse treatment patients: a feasibility study. www.clinicaltrials.gov/ct2/show/NCT00408265 Date first received: 4 December 2006.
Alessi 2008 {published data only}
    1. Alessi SM, Petry NM, Urso J. Contingency management promotes smoking reductions in residential substance abuse patients. Journal of Applied Behavior Analysis 2008;41(4):617‐22. - PMC - PubMed
Alessi 2014 {published data only}
    1. Alessi SM, Petry NM. Smoking reductions and increased self‐efficacy in a randomized controlled trial of smoking abstinence ‐ contingent incentives in residential substance abuse treatment patients. Nicotine & Tobacco Research 2014;16(11):1436‐45. [CENTRAL: 1036730; CRS: 9400050000000133; EMBASE: 2014920182] - PMC - PubMed
Covey 1993 {published data only}
    1. Covey LS, Glassman AH, Stetner F, Becker J. Effect of history of alcoholism or major depression on smoking cessation. American Journal of Psychiatry 1993;150(10):1546‐7. [PUBMED: 8379564] - PubMed
Diehl 2006 {published data only}
    1. Diehl A, Nakovics H, Croissant B, Smolka MN, Batra A, Mann K. Galantamine reduces smoking in alcohol‐dependent patients: a randomized, placebo‐controlled trial. International Journal of Clinical Pharmacology and Therapeutics 2006;44(12):614‐22. [PUBMED: 17190371] - PubMed
Dunn 2008 {published data only}
    1. Dunn KE, Saulsgiver KA, Sigmon SC. Contingency management for behavior change: applications to promote brief smoking cessation among opioid‐maintained patients. Experimental and Clinical Psychopharmacology 2011;19(1):20‐30. - PMC - PubMed
    1. Dunn KE, Sigmon SC, Thomas CS, Heil SH, Higgins ST. Voucher‐based contingent reinforcement of smoking abstinence among methadone‐maintained patients: a pilot study. Journal of Applied Behavior Analysis 2008;41(4):527‐38. - PMC - PubMed
Dunn 2010 {published data only}
    1. Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. A contingency‐management intervention to promote initial smoking cessation among opioid‐maintained patients. Experimental and Clinical Psychopharmacology 2010;18(1):37‐50. - PMC - PubMed
Haug 2004 {published data only}
    1. Haug NA, Svikis DS, Diclemente C. Motivational enhancement therapy for nicotine dependence in methadone‐maintained pregnant women. Psychology of Addictive Behaviors 2004;18(3):289‐92. [PUBMED: 15482085] - PubMed
Higley 2014 {published data only}
    1. Higley AE, Bekman NM, Tibbs JJ, Dinh E, Doran N, Erbacci GE, et al. Predictors of treatment completion for smoking cessation in dually disordered, abstinent alcohol dependent men: a preliminary analysis. Alcoholism, Clinical and Experimental Research 2014;38(Suppl S1):58A. [CENTRAL: 993970; CRS: 9400129000002293; EMBASE: 71503316]
Kalman 2006 {published data only}
    1. Kalman D, Kahler CW, Garvey AJ, Monti PM. High‐dose nicotine patch therapy for smokers with a history of alcohol dependence: 36‐week outcomes. Journal of Substance Abuse Treatment 2006;30(3):213‐7. - PubMed
    1. Kalman D, Kahler CW, Tirch D, Kaschub C, Penk W, Monti PM. Twelve‐week outcomes from an investigation of high‐dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychology of Addictive Behaviors 2004;18(1):78‐82. [PUBMED: 15008689] - PubMed
Laaksonen 2013 {published data only}
    1. Laaksonen E, Vuoristo‐Myllys S, Koski‐Jannes A, Alho H. Combining medical treatment and CBT in treating alcohol‐dependent patients: effects on life quality and general well‐being. Alcohol & Alcoholism 2013;48(6):687‐93. - PubMed
Leggio 2015 {published data only}
    1. Farokhnia M, Edwards SM, Bollinger J, Amodio J, Zywiak WH, Tidey JW, et al. Baclofen as a pharmacotherapy for the treatment of concurrent alcohol and nicotine dependence: a double‐blind, placebo‐controlled, randomized trial. Neuropsychopharmacology 2014;39:S340. [CENTRAL: 1042499; CRS: 9400129000003927; EMBASE: 71714519] - PMC - PubMed
    1. Leggio L, Zywiak WH, Edwards SM, Tidey JW, Swift RM, Kenna GA. A preliminary double‐blind, placebo‐controlled randomized study of baclofen effects in alcoholic smokers. Psychopharmacology 2015;232(1):233‐43. [CRS: 9400131000000986; PUBMED: 24973894] - PMC - PubMed
Meszaros 2013 {published data only}
    1. Meszaros ZS, Abdul‐Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo‐controlled pilot trial. Journal of Clinical Psychopharmacology 2013;33(2):243‐7. - PubMed
Poling 2010 {published data only}
    1. Poling J, Rounsaville B, Gonsai K, Severino K, Sofuoglu M. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(5):401‐8. [PUBMED: 20716302] - PMC - PubMed
Rohsenow 2008 {published data only}
    1. Rohsenow D, Martin R. Contingency management for smoking in substance abusers (SCMSUD). clinicaltrials.gov/ct2/show/study/NCT00807742 Date first received: 11 December 2008.
Rohsenow 2015b {published data only}
    1. Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Monti PM. Varenicline helps smokers with SUD stop smoking without harming recovery (POS5‐63). Society for Research on Nicotine and Tobacco 21st Annual Meeting; Feb 25‐28 Philadelphia 2015. [CRS: 9400131000000039]
Story 1991 {published data only}
    1. Story J, Stark MJ. Treating cigarette smoking in methadone maintenance clients. Journal of Psychoactive Drugs 1991;23(2):203‐15. - PubMed
Tsoh 2008 {published data only}
    1. Tsoh J. INterventions for Smoking among Persons In REcovery (INSPIRE). clinicaltrials.gov/ct2/show/NCT00714896 Date first received: 9 July 2008.
Wiseman 2005 {published data only}
    1. Wiseman EJ, Williams DK, McMillan DE. Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine‐abusing outpatients wearing nicotine or placebo patches. Experimental and Clinical Psychopharmacology 2005;13(2):102‐10. [PUBMED: 15943543] - PubMed

References to ongoing studies

O'Malley 2012 {published data only}
    1. O'Malley S, Zweben A. 1/2‐multi‐site study: varenicline treatment of alcohol dependent smokers. clinicaltrials.gov/show/NCT01553136 Date first received: 16 Feb 2012. [CRS: 9400131000001798]

Additional references

Abrams 2010
    1. Abrams D, Graham A, Levy D, Mabry P, Orleans C. Boosting population quits through evidence‐based cessation treatment. American Journal of Preventive Medicine 2010;38(S3):S351‐63. - PMC - PubMed
Apollonio 2005
    1. Apollonio DE, Malone RE. Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tobacco Control 2005;14(6):409‐15. - PMC - PubMed
Baca 2009
    1. Baca CT, Yahne CE. Smoking cessation during substance abuse treatment: what you need to know. Journal of Substance Abuse Treatment 2009;36:205‐19. - PubMed
Bobo 1995
    1. Bobo JK, Slade J, Hoffman AL. Nicotine addiction counseling for chemically dependent patients. Psychiatric Services 1995;46(9):945‐7. - PubMed
Bornemann 2016
    1. Bornemann P, Eissa A, Strayer SM. Smoking cessation: what should you recommend?. Journal of Family Practice 2016;65(1):22‐9. - PubMed
Campbell 2003
    1. Campbell I. Nicotine replacement therapy in smoking cessation. Thorax 2003;58:464‐5. - PMC - PubMed
CASA 2012
    1. The National Center on Addiction and Substance Abuse at Columbia University. Addiction Medicine: Closing the Gap between Science and Practice. CASA Columbia Reports 2012.
Chan 2004a
    1. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457‐65. - PubMed
Chan 2004b
    1. Chan AW, Krleža‐Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Canadian Medical Association Journal 2004;171:735‐40. - PMC - PubMed
Ebbert 2007
    1. Ebbert JO, Sood A, Hays JT, Dale LC, Hurt RD. Treating tobacco dependence: review of the best and latest treatment options. Journal of Thoracic Oncology 2007;2(3):249‐56. - PubMed
EPOC 2009
    1. Cochrane EPOC Group. Cochrane Effective Practice and Organisation of Care Group. www.epoc.cochrane.org 2009.
Goldsmith 1993
    1. Goldsmith RJ, Knapp J. Towards a broader view of recovery. Journal of Substance Abuse Treatment 1993;10(2):107‐11. - PubMed
Gudrais 2008
    1. Gudrais E. Unequal American: causes and consequences of the wide ‐ and growing ‐ gap between rich and poor. Harvard Magazine 2008;110(6):22‐9.
Guydish 2007
    1. Guydish J, Passalacqua E, Tajima B, Manser S. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. Journal of Psychoactive Drugs 2007;39(4):423‐33. - PMC - PubMed
Guydish 2011
    1. Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine and Tobacco Research 2011;13:401‐11. - PMC - PubMed
Hays 1999
    1. Hays JT, Schroeder DR, Offord KP, Croghan IT, Patten CA, Hurt RD, et al. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Annals of Behavioral Medicine 1999;21(3):244‐50. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hughes 2000
    1. Hughes JR, Rose GL, Callas PW. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history. Alcoholism: Clinical and Experimental Research 2000;24(11):1633‐8. - PubMed
Hurt 1996
    1. Hurt RD, Offord KP, Croghan IT, Gomez‐Dahl L, Kottke TE, Morse RM, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community‐based cohort. JAMA 1996;275(14):1097‐103. - PubMed
Hurt 2003
    1. Hurt RD, Patten CA. Treatment of tobacco dependence in alcoholics. Recent Developments in Alcoholism 2003;16:335‐59. - PubMed
Hurt 2009
    1. Hurt RD, Ebbert JO, Hays JT, McFadden DD. Treating tobacco dependence in a medical setting. CA: A Cancer Journal for Clinicians 2009;59(5):314. - PMC - PubMed
Joseph 2003
    1. Joseph AM, Nelson DB, Nugent SM, Willenbring ML. Timing of alcohol and smoking cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial. Journal of Addictive Diseases 2003;22(4):87‐107. [PUBMED: 14723480] - PubMed
Kalman 2005
    1. Kalman D, Morissette SB, George TP. Co‐morbidity of smoking in patients with psychiatric and substance use disorders. American Journal on Addictions 2005;14:106‐23. - PMC - PubMed
Lamberg 2004
    1. Lamberg L. Patients need more help to quit smoking. JAMA 2004;292(11):1286‐90. - PubMed
Levy 2010
    1. Levy D, Graham A, Mabry P, Abrams D, Orleans C. Modeling the impact of smoking‐cessation treatment policies on quit rates. American Journal of Preventive Medicine 2010;38(S3):S364‐72. - PMC - PubMed
Mauer 2006
    1. Mauer B. Morbidity and mortality in people with serious mental illness. Alexandria (VA): National Association of State Mental Health Program Directs Medical Directors Council Report; 2006 October. Technical Report 13.
NIDA 2007
    1. National Institute on Drug Abuse. Comorbid drug abuse and mental illness. NIDA Topics in Brief 2007; Vol. October.
NIDA 2012
    1. National Institute on Drug Abuse. Elevated rates of drug abuse continue for second year. NIDA Notes 2012.
Philip Morris 1994
    1. Philip Morris. FYI Edition. Philip Morris 26 October 1994; Vol. Bates No. 2041128423/8548.
Prochaska 2004
    1. Prochaska JJ, Delucchi K, Hall SM. A meta‐analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology 2004;72(6):1144‐56. - PubMed
Psychiatric News 1994
    1. Mental Illness Advocacy Group Battling Hospital Smoking Ban in New York. Psychiatric News 16 September 1994.
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Richter 2006
    1. Richter KP. Good and bad times for treating cigarette smoking in drug treatment. Journal of Psychoactive Drugs 2006;38(3):311‐5. - PubMed
SAMHSA 2011
    1. Substance Abuse and Mental Health Services Administration. Tobacco use cessation policies in substance abuse treatment: administrative issues. SAMHSA Advisory 2011;10(3):1‐4.
Schroeder 2004
    1. Schroeder SA. Tobacco control in the way of the 1998 Master Settlement Agreement. New England Journal of Medicine 2004;292(11):1286‐90. - PubMed
Schroeder 2008
    1. Schroeder SA. Stranded in the periphery ‐ the increasing marginalization of smokers. New England Journal of Medicine 2008;358(21):2284‐6. - PubMed
Schroeder 2009
    1. Schroeder SA. A 51‐year‐old woman with bipolar disorder who wants to quit smoking. JAMA 2009;301(5):522‐31. - PubMed
Thurgood 2016
    1. Thurgood SL, McNeill A, Clark‐Carter D, Brose LS. A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine & Tobacco Research 2016;18(5):993‐1001. - PMC - PubMed
Tsoi 2013
    1. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD007253.pub3] - DOI - PMC - PubMed
USDHSS 2014
    1. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. U.S. DHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
Van der Meer 2013
    1. Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD006102.pub2] - DOI - PubMed
Walsh 2005
    1. Walsh RA, Bowman JA, Tzelepis F, Lecathelinais C. Regulation of environmental tobacco smoke by Australian drug treatment agencies. Australian and New Zealand Journal of Public Health 2005;29(3):276‐8. - PubMed
Ward 2012
    1. Ward KD, Kedia S, Webb L, Relyea GE. Nicotine dependence among clients receiving publicly funded substance abuse treatment. Drug and Alcohol Dependence 2012;125(1‐2):95‐102. - PubMed
WHO 2016a
    1. World Health Organization. Tobacco, 2016. www.who.int/mediacentre/factsheets/fs339/en/ (accessed 2 November 2016).
WHO 2016b
    1. World Health Organization. Management of substance abuse, 2016. www.who.int/substance_abuse/facts/en/ (accessed 2 November 2016).
Williams 2004
    1. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors 2004;29(6):1067‐83. - PubMed
Zullino 2000
    1. Zullino D, Besson J, Schnyder C. Stage of change of cigarette smoking in alcohol‐dependent patients. European Addiction Research 2000;6(2):84‐90. - PubMed

Publication types

MeSH terms